1. Home
  2. VALN vs BGB Comparison

VALN vs BGB Comparison

Compare VALN & BGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$5.47

Market Cap

536.9M

Sector

Health Care

ML Signal

HOLD

Logo Blackstone Strategic Credit 2027 Term Fund of Beneficial Interest

BGB

Blackstone Strategic Credit 2027 Term Fund of Beneficial Interest

HOLD

Current Price

$11.21

Market Cap

496.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VALN
BGB
Founded
2012
2012
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
536.9M
496.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
VALN
BGB
Price
$5.47
$11.21
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$15.50
N/A
AVG Volume (30 Days)
126.9K
151.9K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
N/A
9.75%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$93.87
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.15
$10.85
52 Week High
$12.25
$12.65

Technical Indicators

Market Signals
Indicator
VALN
BGB
Relative Strength Index (RSI) 29.34 47.45
Support Level N/A $10.98
Resistance Level $6.42 $11.51
Average True Range (ATR) 0.27 0.09
MACD 0.08 0.01
Stochastic Oscillator 28.74 40.61

Price Performance

Historical Comparison
VALN
BGB

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About BGB Blackstone Strategic Credit 2027 Term Fund of Beneficial Interest

Blackstone Strategic Credit Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current income. The secondary objective of the fund is to seek the preservation of capital. Under normal market conditions, the Fund invests at least 80% of its Managed Assets in senior, secured floating-rate loans. The fund also invest in second-lien loans and high yield bonds and employs financial leverage, which may increase risk to the Fund. The Fund has a limited term and absent shareholder approval to extend the life of the Fund.

Share on Social Networks: